Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
PubMed laboratory research record [PMID: 3503101] PubMed record related to this compound for laboratory literature review
Nitric Oxide System Interaction: The peptide interacts with the nitric oxide system, which regulates blood vessel dilation and blood flow
Saxenda (liraglutide) Saxenda is a GLP-1 agonist with the active ingredient liraglutide
BPC-157 is not a specifically named WADA substance, but athletes should not assume that means it is cleared, since broad catch-all categories can apply
.webp)
These combined effects result in improved postprandial and fasting glucose levels, along with substantial weight loss that varies by indication and dosetypically 5-13% in type 2 diabetes trials and up to 15-20% in obesity trials at the highest doses (15 mg)
"stack" describes the compounds used together
US$ 22.94
US$ 20.37
US$ 29.65
